BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 25433773)

  • 1. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
    Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Clin Exp Nephrol; 2016 Aug; 20(4):536-543. PubMed ID: 27422619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V
    Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Atypical hemolytic uremic syndrome].
    Sepúlveda RA; Tagle R; Jara A
    Rev Med Chil; 2018 Jun; 146(6):770-779. PubMed ID: 30148909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hemolytic uremic syndrome: from diagnosis to treatment.
    Franchini M
    Clin Chem Lab Med; 2015 Oct; 53(11):1679-88. PubMed ID: 25803082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical hemolytic uremic syndrome.
    Loirat C; Frémeaux-Bacchi V
    Orphanet J Rare Dis; 2011 Sep; 6():60. PubMed ID: 21902819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical HUS caused by complement-related abnormalities].
    Yoshida Y; Matsumoto M
    Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical guides for atypical hemolytic uremic syndrome in Japan.
    Kato H; Nangaku M; Hataya H; Sawai T; Ashida A; Fujimaru R; Hidaka Y; Kaname S; Maruyama S; Yasuda T; Yoshida Y; Ito S; Hattori M; Miyakawa Y; Fujimura Y; Okada H; Kagami S;
    Pediatr Int; 2016 Jul; 58(7):549-55. PubMed ID: 27460397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Hemolytic Uremic Syndrome: A Meta-Analysis of Case Reports Confirms the Prevalence of Genetic Mutations and the Shift of Treatment Regimens.
    Krishnappa V; Gupta M; Elrifai M; Moftakhar B; Ensley MJ; Vachharajani TJ; Sethi SK; Raina R
    Ther Apher Dial; 2018 Apr; 22(2):178-188. PubMed ID: 29250893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.
    Cheong HI; Jo SK; Yoon SS; Cho H; Kim JS; Kim YO; Koo JR; Park Y; Park YS; Shin JI; Yoo KH; Oh D
    J Korean Med Sci; 2016 Oct; 31(10):1516-28. PubMed ID: 27550478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations.
    Hossain MA; Cheema A; Kalathil S; Bajwa R; Costanzo EJ; Cosentino J; Cheng J; Vachharajani T; Asif A
    Saudi J Kidney Dis Transpl; 2018; 29(2):276-283. PubMed ID: 29657193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.